Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by University of Colorado, Denver
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of Colorado, Denver Identifier:
First received: September 19, 2013
Last updated: July 19, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)